CoChat

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets

Open access
Qiu, Xintao, Boufaied, Nadia, Hallal, Tarek, Feit, Avery, de Polo, Anna, Luoma, Adrienne M., Alahmadi, Walaa, Larocque, Janie, Zadra, Giorgia, Xie, Yingtian, Gu, Shengqing, Tang, Qin, Zhang, Yi, Syamala, Sudeepa, Seo, Ji-Heui, Bell, Connor, O’Connor, Edward, Liu, Yang, Schaeffer, Edward M., Jeffrey Karnes, R., Weinmann, Sheila, Davicioni, Elai, Morrissey, Colm, Cejas, Paloma, Ellis, Leigh, Loda, Massimo, Wucherpfennig, Kai W., Pomerantz, Mark M., Spratt, Daniel E., Corey, Eva, Freedman, Matthew L., Shirley Liu, X., Brown, Myles, Long, Henry W., Labbé, David P. · 2022 · Nature Communications
Cited by 159

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

c-MYC (MYC) is a major driver of prostate cancer tumorigenesis and progression. Although MYC is overexpressed in both early and metastatic disease and associated with poor survival, its impact on prostate transcriptional reprogramming remains elusive. We demonstrate that MYC overexpression significantly diminishes the androgen receptor (AR) transcriptional program (the set of genes directly targeted by the AR protein) in luminal prostate cells without altering AR expression. Analyses of clinical specimens reveal that concurrent low AR and high MYC transcriptional programs accelerate prostate cancer progression toward a metastatic, castration-resistant disease. Data integration of single-cell transcriptomics together with ChIP-seq uncover an increase in RNA polymerase II (Pol II) promoter-proximal pausing at AR-dependent genes following MYC overexpression without an accompanying deactivation of AR-bound enhancers. Altogether, our findings suggest that MYC overexpression antagonizes the canonical AR transcriptional program and contributes to prostate tumor initiation and progression by disrupting transcriptional pause release at AR-regulated genes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-022-30257-z

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Metadata

Authors
Qiu, X., Boufaied, N., Hallal, T., Feit, A., de Polo, A., Luoma, A. M., Alahmadi, W., Larocque, J., Zadra, G., Xie, Y., Gu, S., Tang, Q., Zhang, Y., Syamala, S., Seo, J.-H., Bell, C., O’Connor, E., Liu, Y., Schaeffer, E. M., Jeffrey Karnes, R., Weinmann, S., Davicioni, E., Morrissey, C., Cejas, P., Ellis, L., Loda, M., Wucherpfennig, K. W., Pomerantz, M. M., Spratt, D. E., Corey, E., Freedman, M. L., Shirley Liu, X., Brown, M., Long, H. W., & Labbé, D. P.
Venue
Nature Communications
Published
2022-05-13
Volume
13
Issue
1
Pages
2559-2559
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4280566607
Cited by
159
References
18
FWCI
17.20
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets. https://app.cochat.ai/papers/10.1038/s41467-022-30257-z
The paper
Qiu, X., Boufaied, N., Hallal, T., Feit, A., de Polo, A., Luoma, A. M., Alahmadi, W., Larocque, J., Zadra, G., Xie, Y., Gu, S., Tang, Q., Zhang, Y., Syamala, S., Seo, J.-H., Bell, C., O’Connor, E., Liu, Y., Schaeffer, E. M., . . . Labbé, D. P. (2022). MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets. Nature Communications. https://doi.org/10.1038/s41467-022-30257-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.